Your browser doesn't support javascript.
loading
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.
Piccart, M; Hortobagyi, G N; Campone, M; Pritchard, K I; Lebrun, F; Ito, Y; Noguchi, S; Perez, A; Rugo, H S; Deleu, I; Burris, H A; Provencher, L; Neven, P; Gnant, M; Shtivelband, M; Wu, C; Fan, J; Feng, W; Taran, T; Baselga, J.
Affiliation
  • Piccart M; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be.
  • Hortobagyi GN; Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Campone M; Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France.
  • Pritchard KI; Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada.
  • Lebrun F; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Ito Y; Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
  • Noguchi S; Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Perez A; Breast Cancer Centers, Memorial Cancer Institute, Hollywood.
  • Rugo HS; Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Deleu I; Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium.
  • Burris HA; Sarah Cannon Research Institute, Nashville, USA.
  • Provencher L; Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada.
  • Neven P; Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Gnant M; Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Shtivelband M; Ironwood Cancer & Research Centers, Chandler.
  • Wu C; Novartis Pharmaceuticals Corporation, East Hanover.
  • Fan J; Novartis Pharmaceuticals Corporation, East Hanover.
  • Feng W; Novartis Pharmaceuticals Corporation, East Hanover.
  • Taran T; Novartis Pharmaceuticals Corporation, East Hanover.
  • Baselga J; Memorial Sloan-Kettering Cancer Center, New York, USA.
Ann Oncol ; 25(12): 2357-2362, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25231953
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sirolimus / Androstadienes Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sirolimus / Androstadienes Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article